ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)

Stock Information for ADC Therapeutics SA

Loading

Please wait while we load your information from QuoteMedia.